LiteVax

Akkersestraat 50

4061Bj Ophemert

NL

LiteVax

Foundation date

24/05/2012

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

LiteVax BV is a biopharmaceutical company focusing on development and exploitation of innovative vaccine adjuvant concepts. Our mission is to contribute to global health by delivering improved adjuvants for vaccines against infectious and noninfectious diseases. People in developed and developing countries will benefit from better vaccines at lower costs.

Upcoming events

Latest news

  • Muna Therapeutics Announces Strategic Alliance with GSK to Accelerate Development of Novel Treatments for Alzheimer’s Disease

    Friday December 6th 2024

  • VUB and VIB launch new Bio Incubator Brussels on VUB campus

    Friday December 6th 2024

  • Does the menstrual cycle influence the effect of chemotherapy?

    Thursday December 5th 2024